Table 6.
Adverse events among patients ever treated with MKIs (n=206) and chemotherapies (n=127)
| Adverse events | Chemo (n=127) (%) |
MKI (n=206) (%) |
|---|---|---|
| Any adverse event | 22.0 | 19.9 |
| Nausea and vomiting | 12.6 | 1.0 |
| Loss of appetite | 9.4 | 7.3 |
| Hair loss | 8.7 | 1.5 |
| Diarrhea | 7.9 | 11.2 |
| Fatigue | 7.1 | 8.3 |
| Mouth sores | 7.1 | 6.8 |
| Neuropathy | 5.5 | 2.4 |
| Hematologic toxicity | 4.7 | 0.5 |
| Hand-foot syndrome | 4.7 | 8.7 |
| Weight loss | 4.7 | 1.9 |
| Dysphonia | 2.4 | 1.0 |
| Infections | 2.4 | 0.5 |
| Hypertension | 1.6 | 5.8 |
Abbreviation: MKI, multikinase inhibitor.